Market Tracker

07/22 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.36
Delayed Data
As of Jul 22
 -0.03 / -2.16%
Today’s Change
1.23
Today|||52-Week Range
2.66
-29.90%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.39
Today’s open1.36
Day’s range1.35 - 1.40
Volume24,198
Average volume (3 months)41,261
Market cap$53.7M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-54.29%
Earnings growth (this year)+60.19%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-64.19%
P/E ratioNM
Price/Sales2.98
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
CATBCatabasis Pharmaceut...+0.05+1.43%
IMMYImprimis Pharmaceuti...+0.07+1.75%
SCYXSCYNEXIS Inc+0.04+1.78%
RNNRexahn Pharmaceutica...-0.00-0.38%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)$0.25
Annual revenue (last year)$24.6M
Annual profit (last year)-$19.1M
Net profit margin-77.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts